Wendy future of retail top

Amneal Pharmaceuticals Inc.

Amneal, Impax agree to merge

Amneal, Impax agree to merge

NEW YORK — Amneal Pharmaceuticals LLC and Impax Laboratories Inc. plan to merge in an all-stock transaction. An Amneal-Impax merger would create the fifth-largest generics supplier by gross revenue in the United States. To be named Amneal Pharmaceuticals Inc., the new entity will also possess a growing, high-margin specialty drug franchise. Financial terms of the deal

PP_1170x120_10-25-21